Treatment with liraglutide for 16 weeks in patients with type 2 diabetes showed the significant reduction of the secretion rate and plasma concentration of APOC3 after a fat‐rich meal shown by the injection of [5,5,5‐2H3]leucine and ultrasensitive mass spectrometry techniques.57 Here, APOC3 is linked to type 2 diabetes mellitus.